KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 26th Apr 2024 ADXS stock ended at $0.555. This is 0.91% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 0.91% from a day low at $0.550 to a day high of $0.555.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Jan 09, 2024 $0.601 $0.662 $0.601 $0.650 9 850
Jan 08, 2024 $0.590 $0.618 $0.588 $0.593 11 915
Jan 05, 2024 $0.600 $0.600 $0.590 $0.590 58 139
Jan 04, 2024 $0.623 $0.632 $0.590 $0.600 10 983
Jan 03, 2024 $0.640 $0.642 $0.627 $0.627 27 009
Jan 02, 2024 $0.646 $0.700 $0.630 $0.630 4 804
Dec 29, 2023 $0.640 $0.760 $0.630 $0.667 20 635
Dec 28, 2023 $0.650 $0.750 $0.630 $0.750 3 707
Dec 27, 2023 $0.638 $0.680 $0.605 $0.650 6 939
Dec 26, 2023 $0.630 $0.670 $0.600 $0.670 13 852
Dec 22, 2023 $0.630 $0.635 $0.600 $0.630 7 920
Dec 21, 2023 $0.665 $0.665 $0.630 $0.630 8 720
Dec 20, 2023 $0.650 $0.713 $0.650 $0.665 12 670
Dec 19, 2023 $0.650 $0.713 $0.650 $0.650 5 509
Dec 18, 2023 $0.660 $0.715 $0.660 $0.664 3 069
Dec 15, 2023 $0.750 $0.770 $0.625 $0.721 8 965
Dec 14, 2023 $0.760 $0.770 $0.760 $0.760 5 010
Dec 13, 2023 $0.80 $0.80 $0.725 $0.760 10 486
Dec 12, 2023 $0.650 $0.86 $0.650 $0.725 8 995
Dec 11, 2023 $0.650 $0.650 $0.600 $0.638 15 721
Dec 08, 2023 $0.680 $0.693 $0.610 $0.615 1 477
Dec 07, 2023 $0.770 $0.82 $0.720 $0.720 4 719
Dec 06, 2023 $0.725 $0.83 $0.725 $0.797 4 379
Dec 05, 2023 $0.565 $0.89 $0.565 $0.770 4 251
Dec 04, 2023 $0.80 $0.88 $0.80 $0.88 869
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT